Related Experiment Video
Updated: Jun 1, 2025
Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Is routine hearing screening necessary in patients with inflammatory bowel disease - a prospective study
Nayanika Reddy1, Vijendra S Shenoy2, Navya Parvathareddy1
1Department of Otorhinolaryngology and Head and Neck Surgery, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.
Purpose:
To compare audiological profiling and association of hearing loss in different types of IBD and evaluate the degree of hearing impairment based on duration of illness and age parameters.
Methods:
120 subjects evaluated at a tertiary centre were divided into 2 groups- Controls and Cases. Cases were sub grouped into Ulcerative colitis (UC) and Crohn's disease based on biopsy. Hearing evaluation was done using PTA and DPOAE. Results were compared between the groups with analysis including duration of illness and age at presentation.
Results:
Mild hearing loss at 8000 Hz was noted in both the subgroups, more so in UC. The median dB loss on PTA was more in the UC group at all the frequencies but was significant only at 1000, 2000, 4000 and 8000 Hz. 53(44.1%) of the 120 ears, showed mild hearing loss at 8000 Hz on PTA. The median SNR was lower in both subgroups at 8000 Hz. At 8000 Hz on DPOAE, 80 ears (66.6%) showed absent response which was much higher as compared to PTA findings at this frequency. At 8000 Hz, patients with > 5 years duration of illness and those with age > 30 years, showed higher absent DPOAE responses namely 25 ears (83.4%) out of 30 ears and 56 ears (80%) of 70, respectively.
Conclusion:
UC cases are more susceptible to hearing loss compared to Crohn's disease especially at 8000 Hz. DPOAE supersedes PTA as a diagnostic tool for subclinical hearing loss.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...